Stanozolol
Stanozolol (pronunciation: /stæˈnoʊzəˌlɔːl/), also known as Winstrol or Winny, is a synthetic anabolic steroid derived from Dihydrotestosterone (DHT). It was developed by American pharmaceutical company Winthrop Laboratories in 1962 and has been approved by the Food and Drug Administration for human use.
Etymology
The name "Stanozolol" is derived from the chemical structure of the drug, which is a combination of the words "stano" (from the chemical name stanolone) and "olol" (a common suffix for steroids).
Pharmacology
Stanozolol has a high oral bioavailability due to a C17 α-alkylation which allows the hormone to survive first-pass liver metabolism when ingested. It is used in the treatment of hereditary angioedema, which causes episodes of swelling of the face, extremities, genitals, bowel wall, and throat.
Side Effects
Like all anabolic steroids, stanozolol is potentially harmful if misused. It can cause side effects such as liver damage, changes in blood lipids, and potential harm to the heart. It is also a controlled substance under the Anabolic Steroids Control Act of 1990 and has been assigned to Schedule III.
Related Terms
See Also
External links
- Medical encyclopedia article on Stanozolol
- Wikipedia's article - Stanozolol
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski